Hammer, Hilde Berner http://orcid.org/0000-0001-7317-8991
Michelsen, Brigitte
Sexton, Joe
Uhlig, Till
Provan, Sella A.
Funding for this research was provided by:
AbbVie
Roche
Pfizer
Article History
Received: 7 June 2020
Revised: 8 September 2020
Accepted: 12 September 2020
First Online: 11 October 2020
Compliance with ethical standards
:
: HBH has received fees for speaking and/or consulting from AbbVie, BMS, Pfizer, UCB, Roche, MSD, Lilly and Novartis.Brigitte Michelsen has received consulting fees and research grant from Novartis, Sella Provan, Joe Sexton, and Till Uhlig have no competing interests.
: The study (ExternalRef removedidentifier ACTRN12610000284066) was approved by the Norwegian Regional Committee for Medical and Health Research Ethics South East (reference number 2009/1254).
: The patients gave their written informed consent according to the Declaration of Helsinki.
: All authors have given their consent for publication.